Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06480578 · ClinicalTrials.gov registry record · Phase 2
An Integrated Intervention Using a Pill Ingestible Sensor System
A Phase 2 study of HIV/AIDS and Medication Adherence, sponsored by University of California, Los Angeles.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 110
- Enrollment target
- 1
- Study location
NCT06480578 is a Phase 2 study of HIV/AIDS and Medication Adherence that is actively recruiting participants, run by University of California, Los Angeles. The registered enrollment target is 110 participants, below the 33,179-participant average among 61 other HIV/AIDS trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06480578, a Phase 2 study of HIV/AIDS and Medication Adherence, is actively recruiting participants, sponsored by University of California, Los Angeles.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 110 participants
- Enrollment target
- 1
- Study location
Study Summary
This study integrates technology-based adherence measures with alerts for social and behavioral determinants of health (SBDOH) to improve HIV treatment outcomes. It involves 110 adult patients from a Los Angeles County HIV clinic, focusing on those at risk for poor adherence. Participants will be randomized into intervention or usual care groups, with endpoints including intervention acceptability, SBDOH interventions, adherence to ART, viral load, and high-risk sexual activity. The study aims to assess the effectiveness of the integrated intervention in improving adherence, virologic outcomes, and reducing high-risk behavior among PLWH.
Conditions Studied
Interventions
- BEHAVIORAL ISS-SBDOH arm
Study Locations (1)
California
- Lundquist - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 110 participants |
| Start Date | 2024-12-19 |
| Est. Completion | 2027-07-01 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06480578
The ClinicalTrials.gov registry entry for NCT06480578 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 110 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 33,179-participant average among 61 other HIV/AIDS trials with a reported enrollment target (100% lower). The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with HIV/AIDS appearing as the primary indexed condition, and to 1 intervention - of which ISS-SBDOH arm is the first listed.
NCT06480578 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT06480578 about?
NCT06480578 is a clinical study titled "An Integrated Intervention Using a Pill Ingestible Sensor System". This study integrates technology-based adherence measures with alerts for social and behavioral determinants of health (SBDOH) to improve HIV treatment outcomes. It involves 110 adult patients from a Los Angeles County HIV clinic, focusing on those at risk for poor adherence. Participants will be ra...
What is the current status of trial NCT06480578?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 110 participants. The study started on 2024-12-19. Estimated completion is 2027-07-01.
What conditions does trial NCT06480578 study?
This clinical trial studies the following conditions: HIV/AIDS, Medication Adherence, Social Determinants of Health (SDOH).
What interventions are being tested in trial NCT06480578?
The interventions under investigation include: ISS-SBDOH arm (BEHAVIORAL).
Who is sponsoring clinical trial NCT06480578?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06480578 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV/AIDS
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Effects of Semaglutide in HIV-Associated Lipohypertrophy
ACTIVE NOT RECRUITING · Phase 2
-
A Mobile Gaming App to Improve Adherence to PrEP
RECRUITING · NA
-
LinkPositively+ A Mobile Health App Delivered Intervention to Improve HIV Care Outcomes Among Black Women Affected by Mental Health and Violence
RECRUITING · NA
-
MyPEEPS Mobile Plus: A Multi-Level HIV Prevention Intervention for Young MSM
RECRUITING · NA
-
MyPEEPS LITE Trial
RECRUITING · NA
-
Project I Test: Implementing HIV Testing in Opioid Treatment Programs
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.